Skip to main content
Premium Trial:

Request an Annual Quote

Millipore's Q1 Sales Rise 14 Percent

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Millipore reported after the close of the market Thursday that its first-quarter revenues rose 14 percent, which includes a five percent favorable impact from foreign currency changes.

The company had total revenues of $463 million for the three-month period ended April 3, compared to $407.9 million for Q1 2009. It beat analysts' consensus estimate for revenues of $436.7 million.

Millipore's Bioscience Division had revenues of $204.7 million, up 15 percent year over year from $177.9 million, while its Bioprocess Division had 12 percent revenue growth to $258.3 million from $230 million.

"We developed exceptional revenue growth in the first quarter, as we benefitted from the contribution of new products, a strengthening economic environment, and continued momentum in our core business," Millipore Chairman and CEO Martin Madaus said in a statement. "Our results were well-balanced between both divisions, and from a geographical perspective we generated impressive results in North American and Asia."

Millipore's net income for the quarter was $57.2 million, or $.99 per share, up from $53.6 million, or $.95 per share, in the first quarter least year. On an adjusted basis, Millipore's EPS was $1.21, beating analysts' consensus estimate of $1.09.

Millipore's R&D spending for the quarter was $30.1 million, up 19 percent year over year from $25.2 million, and its SG&A expenses were $141.1 million, an increase of 11 percent over last year's Q1 costs of $126.8 million.

At the end of the quarter, Millipore had $222.7 million in cash and cash equivalents.

During the quarter, Millipore agreed to be acquired by Merck KGaA for $7.2 billion. That deal will be voted on at a special shareholder's meeting in June.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.